Phosphoinositide-specific phospholipase C isoforms are conveyed by osteosarcoma-derived extracellular vesicles
Authors:
- Enrica UrciuoliEUEnrica Urciuoli
- Martina LeopizziMLMartina Leopizzi
- Valeria Di MaioVMValeria Di Maio
- Stefania PetriniSPStefania Petrini
- Valentina D’oRiaVDValentina D’oRia
- Ezio GiordaEGEzio Giorda
- Marco ScarsellaMSMarco Scarsella
- Carlo Della RoccaCRCarlo Della Rocca
- Vincenza Rita Lo VascoVVVincenza Rita Lo Vasco
- Barbara PeruzziBPBarbara Peruzzi
- 24 June 2020
- journal article
- research article
- Published by Wiley in Journal of Cell Communication and Signaling
- Vol. 14 (4) , 417-426
Abstract
Cancer cells are able to release high amounts of extracellular vesicles, thereby conditioning the normal cells in the surrounding tissue and/or in distant target organs. In the context of bone cancers, previous studies suggested that osteosarcoma cancer cells produce transforming extracellular vesicles able to induce a tumour-like phenotype in normal recipient cells. Indeed, phosphoinositide-specific phospholipase C (PI-PLC) enzymes are differentially expressed in osteosarcoma cell lines with increasing aggressiveness, thus providing helpful insights to better define their role and functions in this bone tumour. By confocal microscopy analysis, we demonstrated that osteosarcoma-derived extracellular vesicles convey all the assessed PI-PLC isoforms, and that they localize into cell membrane bubble-like structures, resembling extracellular vesicles about to be released, as conveyed and/or membrane protein. Cytofluorimetric analysis confirmed the presence of PI-PLC isoforms in the extracellular vesicles collected from conditioned media of osteosarcoma cells. These findings suggest the feasibility to use circulating extracellular vesicles as biomarkers of osteosarcoma progression and/or the monitoring of this distressing disease.Keywords
This publication has 39 references indexed in Scilit:
- Expression of Phosphoinositide-specific phospholipase C enzymes in human osteosarcoma cell linesJournal of Cell Communication and Signaling, 2013
- Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cellsBreast Cancer Research, 2012
- Phospholipase Cγ2 is required for basal but not oestrogen deficiency–induced bone resorptionEuropean Journal of Clinical Investigation, 2011
- Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cellsProceedings of the National Academy of Sciences, 2011
- Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandinsJournal of Lipid Research, 2010
- Signalling in the genomic eraJournal of Cell Communication and Signaling, 2010
- Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDSProceedings of the National Academy of Sciences, 2009
- Phospholipase Cγ2 Modulates Integrin Signaling in the Osteoclast by Affecting the Localization and Activation of Src KinaseMolecular and Cellular Biology, 2008
- Molecular Pathogenesis of OsteosarcomaDNA and Cell Biology, 2007
- The Pleckstrin Homology Domain of Phospholipase C-β2 as an Effector Site for RacJournal of Biological Chemistry, 2003